Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab

被引：3

作者：

Bersanelli, Melissa ^{[1
]}

Gnetti, Letizia ^{[2
]}

Azzoni, Cinzia ^{[2
]}

Bottarelli, Lorena ^{[2
]}

Sverzellati, Nicola ^{[3
]}

Campanini, Nicoletta ^{[2
]}

Varotti, Elena ^{[2
]}

Corrado, Michele ^{[3
]}

Parziale, Raffaele ^{[3
]}

Rapacchi, Elena ^{[1
]}

Caruso, Giuseppe ^{[1
]}

Leonardi, Francesco ^{[1
]}

Silini, Enrico Maria ^{[2
]}

Buti, Sebastiano ^{[1
]}

机构：

[1] Univ Hosp Parma, Med Oncol, Via Gramsci 14, I-43126 Parma, Italy

[2] Univ Hosp Parma, Pathol Anat Unit, Via Gramsci 14, I-43126 Parma, Italy

[3] Univ Hosp Parma, Radiol Unit, Via Gramsci 14, I-43126 Parma, Italy

来源：

IMMUNOTHERAPY | 2018年 / 10卷 / 09期

关键词：

FHIT; loss of heterozygosity; renal cell carcinoma; SPORADIC BREAST-CANCER; CLEAR-CELL CARCINOMA; MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; OVARIAN-CANCER; BRCA2; VHL; 3P; TUMORIGENESIS; GUIDELINES;

D O I：

10.2217/imt-2017-0160

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Aim: We studied the possible clinical significance of loss of heterozygosity (LOH) at key tumor suppressor genes loci in advanced renal cancer patients treated with nivolumab. Methods: LOH study was performed on 3p14.2 (FHIT gene); 3p21.3-21.2; 9p21 (BDMF gene); 9p22 (SH3GL2 gene). Results: Of 12 patients, 8 (67%) had LOH. The most affected gene was FHIT. All five patients with LOH at FHIT locus had good outcome, mean progression free survival of 6.8 months. The patients LOH negative at FHIT locus had mean progression free survival of 4 months, 67% were treatment refractory. Overall, 75% of patients with LOH of at least one gene had benefit; 75% of LOH negative cases were refractory. Conclusion: LOH at key tumor suppressor genes should be further investigated as predictive for immunotherapy.

引用

页码：743 / +

页数：11

共 50 条

[21] Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma
Zhang, Xiaoying
Li, Hiu Ming
Liu, Zhiyan
Zhou, Gengyin
Zhang, Qinghui
Zhang, Tingguo
Zhang, Jianping
Zhang, Cuijuan
JOURNAL OF GASTROENTEROLOGY, 2013, 48 (01) : 132 - 143
[22] Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma
Piao, Z
Kim, H
Jeon, BK
Lee, WJ
Park, C
CANCER, 1997, 80 (05) : 865 - 872
[23] Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma
Xiaoying Zhang
Hiu Ming Li
Zhiyan Liu
Gengyin Zhou
Qinghui Zhang
Tingguo Zhang
Jianping Zhang
Cuijuan Zhang
Journal of Gastroenterology, 2013, 48 : 132 - 143
[24] Malignant mixed tumors of the salivary gland: a study of loss of heterozygosity in tumor suppressor genes
Fowler, MH
Fowler, J
Ducatman, B
Barnes, L
Hunt, JL
MODERN PATHOLOGY, 2006, 19 (03) : 350 - 355
[25] SEARCHING FOR TUMOR-SUPPRESSOR GENES - CHROMOSOMAL DELETIONS AND LOSS OF HETEROZYGOSITY IN HUMAN TUMORS
BERGER, R
BULLETIN DU CANCER, 1993, 80 (08) : 713 - 716
[26] Loss of heterozygosity of tumor suppressor genes in cytologically atypical areas in Hashimoto's thyroiditis
Hunt, JL
Baloch, Z
Barnes, EL
Swalsky, PA
Trusky, CL
Sasatomi, E
Finkelstein, S
LiVolsi, VA
LABORATORY INVESTIGATION, 2002, 82 (01) : 116A - 116A
[27] Loss of heterozygosity among tumor suppressor genes in invasive and in situ carcinoma of the uterine cervix
Lu, X
Nikaido, T
Toki, T
Zhai, YL
Kita, N
Konishi, I
Fujii, S
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (06) : 452 - 458
[28] Fastest Time to Cancer by Loss of Tumor Suppressor Genes
Sanchez-Tapia, Cynthia
Wan, Frederic Y. M.
BULLETIN OF MATHEMATICAL BIOLOGY, 2014, 76 (11) : 2737 - 2784
[29] Fastest Time to Cancer by Loss of Tumor Suppressor Genes
Cynthia Sanchez-Tapia
Frederic Y. M. Wan
Bulletin of Mathematical Biology, 2014, 76 : 2737 - 2784
[30] NF1 tumor suppressor gene in colon cancer: loss of heterozygosity
Kapitanovic, S
Cacev, T
Pavelic, K
Spaventi, R
INTERNATIONAL JOURNAL OF CANCER, 2002, : 333 - 334

← 1 2 3 4 5 →